Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
field ablation (nsPFA) technology, outlined plans for a U.S. investigational device exemption (IDE) study in atrial fibrillation (AF), and discussed capital allocation priorities during a conversation with Oppenheimer Senior Medical Device Analyst Suraj Kalia. European feasibility data: high rhythm control rates CEO Paul LaViolette said the company was “very pleased” with the European feasibility study (EFS) results for its NS 360 catheter that were presented at AF Symposium. He cited the following outcomes: 100% rhythm control at six months 96% rhythm control at 12 months 90% freedom from all atrial arrhythmias at 12 months, which he said included event and intermediate monitoring ? Forget Chipmakers: Walmart and Target Are the Real AI Plays LaViolette characterized the rhythm control levels as “unprecedented,” adding that the clinical community is asking how the results could be so positive. Why management believes nsPFA is different In discussing what may be drivi
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- ???????????????????? : ???????????????2035??3?3534?????? CAGR9%??????????????????????????? [CNET News]CNET News
- Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on Johnson & Johnson: “It's a Textbook Slowdown Stock” [Yahoo! Finance]Yahoo! Finance
- Origin Materials and HP Embalagens enter PET cap distribution deal [Yahoo! Finance]Yahoo! Finance
- Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/18/26 - Form 13F-HR/A
- 3/18/26 - Form 13F-HR/A
- 3/12/26 - Form 4
- JNJ's page on the SEC website